Net Sales Increased 16.8% to $43.5 Million; June 2011 Comparable Store Sales Increased 9.8%
Zumiez Inc. (NASDAQ:ZUMZ), a leading specialty retailer of action sports related apparel, footwear, equipment and accessories, announced that total net sales for the five-week period ended July 2, 2011 increased 16.8% to $43.5 million, compared to $37.2 million for the five-week period ended July 3, 2010. The Company’s comparable store sales increased 9.8% for the five-week period, on top of a comparable store sales increase of 10.9% in the year ago period.
To hear the Zumiez prerecorded June sales message, please dial (585) 295-6795 or (866) 862-7693 (no passcode is required).
Zumiez is a leading specialty retailer of action sports related apparel, footwear, equipment and accessories. Our stores cater to young men and women between ages 12-24, focusing on skateboarding, surfing, snowboarding, motocross and BMX. As of July 2, 2011 we operated 415 stores in the United States and 3 stores in Canada, which are primarily located in shopping malls, and our web site address is www.zumiez.com.
AllianceBernstein National Municipal Income Fund, Inc. (NYSE:AFB), a closed-end management investment company, declared on this date, June 28, 2011, a monthly distribution of $0.0775 per share of Common Stock, payable July 22, 2011 to shareholders of record at the close of business on July 8, 2011. AllianceBernstein National Municipal Income Fund, Inc. is managed by AllianceBernstein L.P.
AllianceBernstein National Municipal Income Fund, Inc is a closed-ended fixed income mutual fund launched and managed by AllianceBernstein L.P.
Power3 Medical Products Inc. (PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
The NuroPro Blood Test is Power3 Medical’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
Parkinson’s disease develops as a result of the inability of nerves to carry signals within the brain. Normally a chemical called dopamine allows nerves in the brain that control movement to transmit signals to each other. As the cells that make dopamine die Parkinson’s disease progresses. The cause of cell death leading to Parkinson’s disease remains a mystery although many theories have been put forward.
The primary problem in Parkinson’s disease is a lack of the chemical called dopamine. Therefore, most of the medications used to treat the condition are aimed at replacing this chemical.
The NuroPro Test is currently in the development stages. The company has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 Medical has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer’s disease and Parkinson’s disease.
For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com
AZZ Incorporated (NYSE:AZZ) announced unaudited financial results for the first quarter ended May 31, 2011. Revenues for the first quarter were $114.3 million compared to $77.5 million for the same quarter last year, an increase of 48 percent. Net income for the quarter was $9.5 million, or $0.75 per diluted share, compared to net income of $6.4 million, or $0.51 per diluted share, in last year’s first fiscal quarter.
AZZ Incorporated manufactures electrical equipment and components for power generation, transmission and distribution, and industrial markets primarily in the United States and Canada.
Teekay Corporation (NYSE:TK) announced it has signed a memorandum of understanding (MOU) with A2SEA A/S (A2SEA) to jointly develop an innovative vessel design for the installation of offshore wind foundations. A2SEA is a leading service provider to the offshore wind sector.
Teekay Corporation provides crude oil and petroleum product transportation services in Bermuda and internationally.
Chemtura Corporation (NYSE:CHMT) announced it will issue its 2011 Second Quarter earnings release and file its Quarterly Report on Form 10-Q on Wednesday, August 3, 2011 after the market closes. The company will host a teleconference to review these results on Thursday, August 4, 2011, at 9:00 AM (EDT). Copies of the release, as well as informational slides, and a webcast of the teleconference will be available on the Investor Relations section of the company’s website at www.chemtura.com.
Chemtura Corporation, together with its subsidiaries, engages in the manufacture and sale of specialty chemical solutions and consumer products worldwide.
Peabody Energy Corp. (NYSE:BTU) confirmed that the Government of Mongolia has selected Peabody to be part of a global energy consortium to develop the Tavan Tolgoi coking coal reserve in the South Gobi region. Peabody continues to work with the government and other parties to reach agreement on definitive terms and conditions. Agreements would then be submitted for consideration and approval by government agencies and Parliament.
Peabody Energy Corporation, through its subsidiaries, engages in the exploration, mining, and production of coal.
No comments:
Post a Comment